ADR News Bulletin 2024 December (Volume 26 Number 3)

Bulletin Highlights:

  • Potential risk of psychiatric withdrawal events with domperidone for stimulation of lactation
  • Overview of serious adverse event reports associated with programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) immune checkpoint inhibitors
  • Biosimilars evaluation: Update on HSA’s regulatory considerations for clinical comparability studies
  • AE Case in Focus: Test Yourself - What could have contributed to the patient's euglycaemic diabetic ketoacidosis (eDKA)?

 

Click on the link below to download the issue in pdf:

ADR_News_Dec2024_Vol26_No3

Healthcare professional, Industry member, Therapeutic Products
Published:

Adverse Drug Reaction News Bulletins

30 Dec 2024
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.